Showing Results for: “diabetes”

Study Featuring Cleveland Clinic Data Underscores the Importance of Treating Obesity as a Chronic Disease Today, data from a retrospective observational study conducted using the electronic health record at the Cleveland Clinic, shows that real-world weight loss can be associated with a reduced risk of obesity-related cancers. The findings were presented as a Late-Breaking Poster at the 84 th Scientific Sessions of the American Diabetes Association® (ADA) in Orlando, FL. Overall, 78% of people with diabetes have clinical obesity. Obesity is linked to higher risks of at least 13 types of cancer

Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment Today, findings from the QWINT-1 study found once-weekly insulin efsitora alfa (efsitora) lowered blood glucose (blood sugar) levels as effectively as daily basal insulin in insulin-naïve type 2 diabetes. The results of the first-of-its-kind study were presented as a late-breaking symposium at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago and simultaneously published in The New England Journal

The study examined the potency and consistency of active insulin in products available across the United States JDRF, the American Diabetes Association (ADA), and The Leona M. and Harry B. Helmsley Charitable Trust, announced the results of a study examining the consistency and potency of insulin purchased at U.S. retail pharmacies. The study, led by University of Florida researcher Timothy Garrett and published today in Diabetes Care, found all human and analog insulins measured contained the expected quantity of active insulin. Insulin is a life-saving drug for people with diabetes that can

First Head-to-Head Trial Compares Two Oral GLP-1 RAs Effects on Glucose Control and Weight Changes in Type 2 Diabetes New data show the benefits of orforglipron, the first oral, small molecule, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) to successfully complete a phase 3 program, for blood glucose and weight management in individuals living with type 2 diabetes, compared to existing treatment options. Researchers presented this data as symposia at the 2026 Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans. This follows findings from the

Findings highlight potential to expand oral GLP-1 RA treatment options for patients with type 2 diabetes and obesity Findings from two phase 2 studies demonstrated positive outcomes for elecoglipron, an investigational oral, once-daily, small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA), in patients with type 2 diabetes and obesity with weight-related comorbidities. The studies showed reductions in body weight, improvements in A1C (a key measure of average blood glucose levels) and cardiometabolic measures along with a favorable safety profile. Researchers presented data from

The Collaboration for Equitable Health with Black Nurses Rock DMV provided health care education, health screenings, and food packages for underserved Washingtonians Yesterday, The Collaboration for Equitable Health, a national partnership between the American Diabetes Association ®, American Heart Association ®, American Cancer Society ®, the University of Michigan School of Public Health, and powered by Bank of America, hosted the Back-to-School Wellness Expo tackling chronic diseases in D.C. alongside local community health organization Black Nurses Rock DMV Chapter and resident services

Henderson Brings a Commitment to Stability, Growth, and Impact to the Nation's Leading Diabetes Organization The American Diabetes Association ® (ADA), the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic, is proud to announce Charles D. “Chuck” Henderson as the new Chief Executive Officer (CEO). Following six months of serving in the interim office of the CEO, Charles was selected from a pool of highly qualified candidates to serve in this position in a search led by the Furst Group, which is ranked as a Top 10 executive search firm by Modern

American Diabetes Association, Black Lives Matter, NAACP, AARP and others urge Congress to make testing more accessible through mobile units, community health workers and other means The American Diabetes Association® (ADA) today, along with over 100 other national groups, sent a letter to congressional leaders calling for them to focus their efforts for increasing testing in the most vulnerable communities as they continue to be hardest hit by the COVID-19 pandemic. Groups such as Black Lives Matter Global Network, the NAACP, AARP, Boys and Girls Club of America, the American Nurses

SURMOUNT-OSA Study Highlights Potential Dual-Action Benefits of Novel Therapy for Obesity Today, findings from the SURMOUNT-OSA, a study of tirzepatide in patients with obstructive sleep apnea (OSA) and obesity, were announced, revealing significant improvements in both sleep apnea severity and related metabolic issues. The results were presented as a Late-Breaking Symposium at the 84th Scientific Sessions of the American Diabetes Association® (ADA) in Orlando, FL, and were simultaneously published in the New England Journal of Medicine (NEJM). OSA affects up to 1 billion people globally and

The No-Cost Diabetes Risk Reduction Program Aims to Slow Trajectory of Childhood Obesity This year, Aurora Public Schools (APS) and the American Diabetes Association ® (ADA), through the Collaboration for Equitable Health, have teamed up to launch the ADA's Project Power for youth initiative at several local schools. During this national Move More Month, students at Jewell Elementary School participated in the program during their third grade physical education (PE) class. “We’re excited to bring Project Power into our school,” said Lacy Jolly, principal at Jewell Elementary School. “Creating